Suppr超能文献

侵袭性非霍奇金淋巴瘤患者的患者报告症状负担及健康相关生活质量:一项横断面研究

Patient-reported symptom burden and health-related quality of life in patients with aggressive Non-Hodgkin lymphoma: a cross-sectional study.

作者信息

Jin Jiayue, Ren Simeng, Zhang Wei, Yang Ping, Yang Jingqi, Xu Hongkun, Han Baojin, Zhang Wenzheng, Liu Jie

机构信息

Guang'anmen Hospital and China Academy of Chinese Medical Sciences, Beijing, China.

The Third Affiliated Hospital of Changchun University of Chinese Medicine, Jilin, China.

出版信息

BMC Cancer. 2025 Sep 1;25(1):1406. doi: 10.1186/s12885-025-14730-8.

Abstract

BACKGROUND

Patient-reported health-related quality of life (HRQoL) impacted by symptom burden is predictive of overall survival in patients with aggressive Non-Hodgkin lymphoma (NHL).

METHOD

This cross-sectional study investigated the Core Symptoms Burden Set (CSBS) significantly affecting the HRQoL in patient with aggressive NHL and identify a single cutoff point to separate clinical difference. The MDASI-TCM and EQ-5D-5 L were used to assess the symptom (severity and interference) and HRQoL. The t test, chi-square test or Wilcoxon rank-sum test were used to determine differences in symptoms burden between during and after cancer therapies. A multivariate linear regression model was used to identify associations between the CSBS and HRQoL. Receiver operating characteristic curves were used to identify optimum cutoff point considered the grading scale (0 vs. 1-3) of the ECOG as the anchor.

RESULTS

Total 116 eligible patients with aggressive NHL were analyzed. The CSBS were disturbed sleep (47.4%), fatigue (44.3%), and difficulty remembering (40.9%). The EQ-5D index value ranged from - 0.294 to 1.0 and the median of EQ VAS was 80(Interquartile: 25). There were 22.4% of patients with "11111" health state. The CSBS demonstrated significantly influence in the physical function (B = 0.442, 95%CI 0.260-0.623, P < 0.001), psychological function (B = 0.674, 95%CI 0.495-0.853, P < 0.001), EQ-5D index value (B = -0.014, 95%CI [-0.027]-[-0.001], P = 0.033) and EQ VAS (B = -3.047, 95%CI [-5.028]-[-1.066], P = 0.003) for the patients with aggressive NHL. The best cutoff point of CSBS with significantly clinical difference was 2.50, with a sensitivity of 82.4% and specificity of 64.6%.

CONCLUSIONS

The Core Symptoms Burden Set of patients with aggressive NHL impacted their HRQoL significantly whose score of 2.50 or higher would be a potential preliminary indicator to be emphasized and intervened.

摘要

背景

症状负担影响的患者报告的健康相关生活质量(HRQoL)可预测侵袭性非霍奇金淋巴瘤(NHL)患者的总生存期。

方法

这项横断面研究调查了显著影响侵袭性NHL患者HRQoL的核心症状负担集(CSBS),并确定一个单一的截断点以区分临床差异。使用MDASI-TCM和EQ-5D-5L评估症状(严重程度和干扰)及HRQoL。采用t检验、卡方检验或Wilcoxon秩和检验来确定癌症治疗期间和之后症状负担的差异。使用多元线性回归模型来确定CSBS与HRQoL之间的关联。采用受试者工作特征曲线,以ECOG分级量表(0对1-3)作为锚点来确定最佳截断点。

结果

共分析了116例符合条件的侵袭性NHL患者。CSBS包括睡眠障碍(47.4%)、疲劳(44.3%)和记忆困难(40.9%)。EQ-5D指数值范围为-0.294至1.0,EQ VAS中位数为80(四分位间距:25)。22.4%的患者处于“11111”健康状态。CSBS对侵袭性NHL患者的身体功能(B = 0.442,95%CI 0.260-0.623,P < 0.001)、心理功能(B = 0.674,95%CI 0.495-0.853,P < 0.001)、EQ-5D指数值(B = -0.014,95%CI [-⁰.027]-[-⁰.001],P = 0.033)和EQ VAS(B = -3.047,95%CI [-5.028]-[-1.066],P = 0.003)有显著影响。CSBS具有显著临床差异的最佳截断点为2.50,敏感性为82.4%,特异性为64.6%。

结论

侵袭性NHL患者的核心症状负担集对其HRQoL有显著影响,其分数2.50及以上将是一个值得重视和干预的潜在初步指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验